Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

33.10p
   
  • Change Today:
    -0.60p
  • 52 Week High: 71.80
  • 52 Week Low: 32.90
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,864,058
  • Market Cap: £178.87m
  • RiskGrade: 119

Latest ShareCast News

Alliance Pharma delays preliminary results

By Josh White

Date: Monday 22 Apr 2024

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.

Alliance Pharma ShareCast News

Alliance Pharma to delay release of 2023 results 05-Apr-2024 ShareCast
Alliance Pharma names Camillo Pane as chair 05-Feb-2024 ShareCast
RBC Capital Markets nudges down Alliance Pharma ... 31-Jan-2024 ShareCast
Alliance Pharma expects no profit growth in 2024 29-Jan-2024 ShareCast
Alliance Pharma confident after some first-half ... 26-Sep-2023 ShareCast

Alliance Pharma Regulatory News

Preliminary Results Publication Date 26-Apr-2024 07:00 RNS
Further update on timing of preliminary results 22-Apr-2024 07:00 RNS
Update on Timing of Preliminary Results 05-Apr-2024 07:00 RNS
Total Voting Rights 02-Apr-2024 11:12 RNS
Total Voting Rights 04-Mar-2024 08:00 RNS

Alliance Pharma Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Alliance Pharma Tips & Analysis

Investment Column : Alliance Pharma 09-Sep-2010 The Independent
Investment Column:Alliance Pharma 19-Mar-2009 The Independent
Market report: Thursday latest 13-Sep-2007 Daily Mail
Gloomy summer casts shadow over Next 10-Sep-2007 The Independent

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 33.10p
Change Today -0.60p
% Change -1.78 %
52 Week High 71.80
52 Week Low 32.90
Volume 1,864,058
Shares Issued 540.40m
Market Cap £178.87m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average
12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average
Income
33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 03-May-2024

Time Volume / Share Price
16:35 83,605 @ 33.10p
16:35 4,891 @ 33.10p
16:35 1,099 @ 33.10p
16:35 1,203 @ 33.10p
16:35 1,817 @ 33.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page